Suchergebnisse

327 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: chemotherapy, Chemotherapie, 化学療法

• 2013, Mansourian M, Firoozabadi SM, Shankayi Z, Hassan ZM
  Magnetic fields with frequency of 217 Hz can reduce cell apoptosis caused by electrochemotherapy [med./bio.]
  Electromagn Biol Med 32 (1): 70-78
• 2013, Kostoff RN, Lau CGY
  Combined biological and health effects of electromagnetic fields and other agents in the published literature [Review]
  Technol Forecast Soc Change 80 (7): 1331-1349
• 2013, Smrkovski OA, Koo Y, Kazemi R, Lembcke LM, Fathy A, Liu Q, Phillips JC
  Performance characteristics of a conformal ultra-wideband multilayer applicator (CUMLA) for hyperthermia in veterinary patients: a pilot evaluation of its use in the adjuvant treatment of non-resectable tumours [med. Anw.]
  Vet Comp Oncol 11 (1): 14-29
• 2012, Kakikawa M, Yamada S
  [Details] Effect of Extremely Low-Frequency (ELF) Magnetic Fields on Anticancer Drugs Potency [med./bio.]
  IEEE Trans Magn 48 (11): 2869-2872
• 2012, De Bonis P, Doglietto F, Anile C, Pompucci A, Mangiola A
  Electric fields for the treatment of glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (10): 1181-1184
• 2012, Fonkem E, Wong ET
  NovoTTF-100A: a new treatment modality for recurrent glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (8): 895-899
• 2012, Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH
  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality [med. Anw.]
  Eur J Cancer 48 (14): 2192-2202
• 2012, Jin Z, Zong C, Jiang B, Zhou Z, Tong J, Cao Y
  The Effect of Combined Exposure of 900 MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells [med./bio.]
  PLoS One 7 (9): e46102
• 2012, Breton M, Mir LM
  [Details] Microsecond and nanosecond electric pulses in cancer treatments [Review]
  Bioelectromagnetics 33 (2): 106-123
• 2011, Tatarov I, Panda A, Petkov D, Kolappaswamy K, Thompson K, Kavirayani A, Lipsky MM, Elson E, Davis CC, Martin SS, Detolla LJ
  Effect of magnetic fields on tumor growth and viability [med./bio.]
  Comp Med 61 (4): 339-345
• 2011, Pless M, Weinberg U
  [Details] Tumor treating fields: concept, evidence and future [Review]
  Expert Opin Investig Drugs 20 (8): 1099-1106
• 2011, Hu YC, Ji JT, Lun DX
  Intraoperative microwave inactivation in-situ of malignant tumors in the scapula [med. Anw.]
  Orthop Surg 3 (4): 229-235
• 2011, Rihova B, Etrych T, Sirova M, Tomala J, Ulbrich K, Kovar M
  Synergistic effect of EMF- BEMER- type pulsed weak electromagnetic field and HPMA-bound doxorubicin on mouse EL4 T-cell lymphoma [med. Anw.]
  J Drug Target 19 (10): 890-899
• 2011, Luo P, Cao P, Yao Z
  [Efficacy of Radiofrequency Hyperthermia Combined with Chemotherapy in Treatment of Malignant Pericardial Effusion Caused by Lung Cancer] [fremdsprachig]
  Zhongguo Fei Ai Za Zhi 14 (7): 593-597
• 2011, Jia D, Rao W, Wang C, Jin C, Wang S, Chen D, Zhang M, Guo J, Chang Z, Liu J
  Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia [med. Anw.]
  Int J Hyperthermia 27 (3): 275-285
• 2011, Zhang D, Pan X, Ohno S, Osuga T, Sawada S, Sato K
  No effects of pulsed electromagnetic fields on expression of cell adhesion molecules (integrin, CD44) and matrix metalloproteinase-2/9 in osteosarcoma cell lines [med./bio.]
  Bioelectromagnetics 32 (6): 463-473
• 2011, Matl FD, Obermeier A, Zlotnyk J, Friess W, Stemberger A, Burgkart R
  Augmentation of antibiotic activity by low-frequency electric and electromagnetic fields examining Staphylococcus aureus in broth media [med./bio.]
  Bioelectromagnetics 32 (5): 367-377
• 2011, Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ
  The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study [med. Anw.]
  Int J Hyperthermia 27 (1): 27-32
• 2010, Schneiderman RS, Shmueli E, Kirson ED, Palti Y
  TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters [med. Anw.]
  BMC Cancer 10: 229
• 2010, Sohrabi MR, Tarjoman T, Abadi A, Yavari P
  [Details] Living near overhead high voltage transmission power lines as a risk factor for childhood acute lymphoblastic leukemia: a case-control study [epidem.]
  Asian Pac J Cancer Prev 11 (2): 423-427
• 2010, Lai HC, Singh NP
  Medical Applications of Electromagnetic Fields [Grundlagen]
  IOP Conf Ser: Earth Environ Sci 10 (1): 2006-
• 2010, Palazzi M, Maluta S, Dall'Oglio S, Romano M
  [Details] The role of hyperthermia in the battle against cancer [Review]
  Tumori 96 (6): 902-910
• 2010, Chen WF, Qi H, Sun RG, Liu Y, Zhang K, Liu JQ
  Static magnetic fields enhanced the potency of cisplatin on k562 cells [med./bio.]
  Cancer Biother Radiopharm 25 (4): 401-408
• 2010, Huilgol NG, Gupta S, Dixit R
  Chemoradiation with hyperthermia in the treatment of head and neck cancer [med. Anw.]
  Int J Hyperthermia 26 (1): 21-25
• 2010, Hintzsche H, Stopper H
  [Details] Micronucleus frequency in buccal mucosa cells of mobile phone users [med./bio.]
  Toxicol Lett 193 (1): 124-130